Psychemedics Corp financial data

Symbol
PMD on Nasdaq
Industry
Services-Medical Laboratories
Location
125 Nagog Park, Acton, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 146 % -18.4%
Debt-to-equity 82.9 % +12.1%
Return On Equity -60.4 % -347%
Return On Assets -33 % -325%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.81 M shares +2.13%
Common Stock, Shares, Outstanding 5.81 M shares +2.11%
Entity Public Float 22.1 M USD -17.8%
Common Stock, Value, Issued 32 K USD 0%
Weighted Average Number of Shares Outstanding, Basic 5.74 M shares +2.03%
Weighted Average Number of Shares Outstanding, Diluted 5.74 M shares +2.03%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 1.06 M USD -19.2%
Selling and Marketing Expense 2.9 M USD -8.6%
General and Administrative Expense 7.33 M USD +18.8%
Operating Income (Loss) -2.96 M USD -84.9%
Nonoperating Income (Expense) -517 K USD 0%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.48 M USD -113%
Income Tax Expense (Benefit) 981 K USD
Net Income (Loss) Attributable to Parent -4.46 M USD -196%
Earnings Per Share, Basic -0.77 USD/shares -185%
Earnings Per Share, Diluted -0.68 USD/shares -94.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.42 M USD -67.6%
Accounts Receivable, after Allowance for Credit Loss, Current 3.88 M USD -4.31%
Assets, Current 6.19 M USD -35.1%
Deferred Income Tax Assets, Net 0 USD -100%
Property, Plant and Equipment, Net 3.06 M USD -33.1%
Operating Lease, Right-of-Use Asset 1.6 M USD -36.9%
Other Assets, Noncurrent 608 K USD -27.6%
Assets 11.2 M USD -37.7%
Accounts Payable, Current 1.13 M USD +44.1%
Accrued Liabilities, Current 1.78 M USD -51%
Liabilities, Current 4.18 M USD -27.7%
Deferred Income Tax Liabilities, Net 7 K USD
Operating Lease, Liability, Noncurrent 687 K USD -60.1%
Liabilities 4.87 M USD -37.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.63 M USD 0%
Retained Earnings (Accumulated Deficit) -17.5 M USD -38.6%
Stockholders' Equity Attributable to Parent 6.28 M USD -38.2%
Liabilities and Equity 11.2 M USD -37.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -473 K USD -110%
Net Cash Provided by (Used in) Financing Activities -75 K USD -4.17%
Net Cash Provided by (Used in) Investing Activities 5 K USD
Common Stock, Shares Authorized 50 M shares 0%
Common Stock, Shares, Issued 6.47 M shares +1.89%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -543 K USD -46.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4 K USD -20%
Deferred Tax Assets, Valuation Allowance 2.58 M USD +188%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 3.52 M USD +14.4%
Operating Lease, Liability 1.7 M USD -39.2%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -1.08 M USD -63%
Lessee, Operating Lease, Liability, to be Paid 2.07 M USD -35.3%
Property, Plant and Equipment, Gross 2.76 M USD -33.5%
Operating Lease, Liability, Current 1.04 M USD -3.07%
Lessee, Operating Lease, Liability, to be Paid, Year Two 553 K USD -47.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.06 M USD -6.44%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 81 K USD -65.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 460 K USD -16.8%
Deferred Tax Assets, Operating Loss Carryforwards 87 K USD +20.8%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 146 K USD
Preferred Stock, Shares Authorized 873 K shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 460 K USD -22.3%
Operating Lease, Payments 287 K USD -1.38%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) -75 K USD -426%
Current Federal Tax Expense (Benefit) 99 K USD -82.1%
Deferred Tax Assets, Net of Valuation Allowance 944 K USD -56.8%
Share-based Payment Arrangement, Expense 1.03 M USD +18.2%
Deferred State and Local Income Tax Expense (Benefit) 546 K USD +27.6%
Interest Expense 17 K USD -46.9%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%